Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma
More about Open Access at the CrickAuthors list
Sujath Abbas Oriol Pich Ginny Devonshire Shahriar A Zamani Annalise Katz-Summercorn Sarah Killcoyne Calvin Cheah Barbara Nutzinger Nicola Grehan Nuria Lopez-Bigas Paul AW Edwards Elwira Fidziukiewicz Aisling M Redmond Adam Freeman Elizabeth C Smyth Maria O’Donovan Ahmad Miremadi Shalini Malhotra Monika Tripathi Hannah Coles Conor Flint Matthew Eldridge Sriganesh Jammula Jim Davies Charles Crichton Nick Carroll Richard H Hardwick Peter Safranek Andrew Hindmarsh Vijayendran Sujendran Stephen J Hayes Yeng Ang Andrew Sharrocks Shaun R Preston Izhar Bagwan Vicki Save Richard JE Skipworth Ted R Hupp J Robert O’Neill Olga Tucker Andrew Beggs Philippe Taniere Sonia Puig Gianmarco Contino Timothy J Underwood Robert C Walker Ben L Grace Jesper Lagergren James Gossage Andrew Davies Fuju Chang Ula Mahadeva Vicky Goh Francesca Ciccarelli Grant Sanders Richard Berrisford David Chan Ed Cheong Bhaskar Kumar L Sreedharan Simon L Parsons Irshad Soomro Philip Kaye John Saunders Laurence Lovat Rehan Haidry Michael Scott Sharmila Sothi Suzy Lishman George B Hanna Christopher J Peters Krishna Moorthy Anna Grabowska Richard Turkington Damian McManus Helen Coleman Russell D Petty Freddie Bartlett Rebecca C Fitzgerald Maria Secrier
Toggle all authors (80)
Abstract
A variety of mutational processes drive cancer development, but their dynamics across the entire disease spectrum from pre-cancerous to advanced neoplasia are poorly understood. We explore the mutagenic processes shaping oesophageal adenocarcinoma tumorigenesis in 997 instances comprising distinct stages of this malignancy, from Barrett Oesophagus to primary tumours and advanced metastatic disease. The mutational landscape is dominated by the C[T > C/G]T substitution enriched signatures SBS17a/b, which are linked with TP53 mutations, increased proliferation, genomic instability and disease progression. The APOBEC mutagenesis signature is a weak but persistent signal amplified in primary tumours. We also identify prevalent alterations in DNA damage repair pathways, with homologous recombination, base and nucleotide excision repair and translesion synthesis mutated in up to 50% of the cohort, and surprisingly uncoupled from transcriptional activity. Among these, the presence of base excision repair deficiencies show remarkably poor prognosis in the cohort. In this work, we provide insights on the mutational aetiology and changes enabling the transition from pre-neoplastic to advanced oesophageal adenocarcinoma.
Journal details
Journal
Nature Communications
Volume
14
Issue number
1
Pages
4239
Available online
Publication date
Full text links
Publisher website (DOI)
10.1038/s41467-023-39957-6
Europe PubMed Central
37454136
Pubmed
37454136
Keywords
Related topics
Type of publication
